The genetic deletion of IL-4 in Ldlr−/− mice reduces atherosclerosis [24], while exogenous administration of IL-4 did not affect atherosclerosis in Apoe−/− mice [25], producing discrepant results. This evidence concerns the gene IL4 and atherosclerosis.